Le Lézard
Classified in: Oil industry, Health
Subject: CSR

CITGO Lemont Reaches Fundraising Record with Annual Shamrock Bowl Benefitting MDA


LEMONT, Ill., April 19, 2018 /PRNewswire/ -- The CITGO Lemont Refinery celebrated St. Patrick's Day in March at their annual Shamrock Bowl for the Muscular Dystrophy Association (MDA) in Romeoville, Illinois. Through bowler registrations, lane sponsorships and raffles, this year's event raised a record $103,000 to benefit the MDA.

MDA Illinois State Goodwill Ambassador, Summer Nagele, presents the trophy for high score to CITGO Lemont employee, Kevin Moss.

CITGO, a longstanding corporate partner of the MDA, hosts a variety of events throughout the year to raise support and awareness for the organization. In addition to the Shamrock Bowl, the CITGO Lemont Refinery hosts a golf outing, spearheads the annual Fill the Boot campaign with local firefighters, and supports the annual Muscle Team benefit dinner.

"Families are at the heart of the MDA's mission, and the CITGO family is dedicated to the fight to end muscle disease. Whether it's participating in an event or sponsoring a child for MDA Summer Camp, I am always amazed by the kindness and generosity shown by our employees and contractors," said Jim Cristman, CITGO Vice President of Refining.

As the MDA's largest corporate sponsor in the United States, CITGO is dedicated to providing health care services and support for MDA families nationwide.

"We cannot fulfill our mission to free kids and adults from the harm of muscle-debilitating diseases without dedicated partners like CITGO and its generosity," said Kate Shea, Regional Director at Muscular Dystrophy Association.

For more than 30 years, TeamCITGO volunteers have led the CITGO-MDA partnership by fundraising and volunteering to advance this important cause. To date, CITGO employees, contractors, vendors, suppliers, Retailers, Marketers, family and friends have helped raise more than $230 million to help find treatments and cures, and rally communities and support families with services like MDA Care Centers, Summer Camps and support groups.

About the CITGO Lemont Refinery
The CITGO Lemont Refinery, which celebrated 90 years of operations in 2016, provides more than 700 jobs locally, while generating an economic impact of more than $470 million per year in support of the local economy through salaries, services and taxes. In addition to producing high-quality fuels for a network of nearly 300 independently owned and operated CITGO branded stations in the State of Illinois and thousands more across the country, CITGO Lemont Refinery employees are dedicated to making a positive difference in their communities. CITGO Lemont employees volunteer more than 2,000 hours on average annually to support causes and organizations including the Special Olympics, Muscular Dystrophy Association, YMCA, United Way and a variety of environmental stewardship programs. For more information, visit www.citgolemont.com.

About CITGO
CITGO, based in Houston, is a refiner, transporter and marketer of transportation fuels, lubricants, petrochemicals and other industrial products. The company is owned by CITGO Holding, Inc., an indirect wholly owned subsidiary of Petróleos de Venezuela, S.A., the national oil company of the Bolivarian Republic of Venezuela. For more information, visit www.citgo.com.

About the MDA
MDA is leading the fight to free individuals ? and the families who love them ? from the harm of muscular dystrophy, ALS and related muscle-debilitating diseases that take away physical strength, independence and life. We use our collective strength to help children and adults live longer and grow stronger by finding research breakthroughs across diseases; caring for individuals from day one; and empowering families with services and support in hometowns across America.

 

SOURCE CITGO


These press releases may also interest you

22 avr 2024
The report titled "Diaphragm Pumps Market by Mechanism (Air-Operated, Electrical-Operated), Operation (Double Acting, Single Acting), Discharge Pressure, End-User - Global Forecast 2024-2030" is now available on 360iResearch.com's offering, presents...

22 avr 2024
ImmunityBio, Inc. , an immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has approved ANKTIVA (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) for the treatment of patients with...

22 avr 2024
Brise Pharmaceuticals Co., LTD. (Brise), a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed  Pre-A and Pre-A+ financing with a total of approximately $20 million. This Pre-A round is led by...

22 avr 2024
PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therapeutics to treat medical unmet needs, announced today that the Company's U.S. subsidiary, Wincal Biopharm, Inc....

22 avr 2024
Vanda Pharmaceuticals Inc. (Vanda) today announced that the Supreme Court denied Vanda's petition for a writ of certiorari in its HETLIOZ® Abbreviated New Drug Application litigation against Teva Pharmaceuticals USA, Inc., Apotex Inc. and Apotex...

22 avr 2024
Globe Life Inc. announces the live audio webcast of its 2024 Annual Meeting of Shareholders, on Thursday, April 25, 2024 at 10:00 a.m. CDT....



News published on and distributed by: